Back to search

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Clinicaltrials.gov:
EU CTIS:
#2023-508425-28-00
EudraCT:
J&J ID:
#CR109195
Other:
#80202135CDP3001
Other:
#2023
Interested in this trial?
Learn more
Subscribe or share this trial
Countries:
  • Argentina,
  • Australia,
  • Canada,
  • China,
  • Colombia,
  • Czechia,
  • France,
  • Germany,
  • Greece,
  • Italy,
  • Japan,
  • Mexico,
  • Poland,
  • Portugal,
  • South Korea,
  • Spain,
  • Taiwan,
  • United Kingdom,
  • United States
Loading...
Enrolling
Miami, Florida, United States, 33136
Enrolling
Milwaukee, Wisconsin, United States, 53215
Enrolling
Thessaloniki, Greece, 54636
Enrolling
Orbassano, Italy, 10043
Enrolling
Athens, Greece, 12462
Enrolling
Augusta, Georgia, United States, 30912
Enrolling
Austin, Texas, United States, 78756
Enrolling
Genova, Italy, 16132
Enrolling
Naples, Italy, 80131
Enrolling
Catania, Italy, 95123
Enrolling
Beijing, China, 100070
Enrolling
Strasbourg, France, 67200
Enrolling
Bordeaux, France, 33000
Enrolling
Nîmes, France, 30029
Enrolling
Milan, Italy, 20144
Enrolling
Porto, Portugal, 4200 319
Enrolling
Chiba, Japan, 260-8677
Enrolling
Chifeng, China, 024000
Enrolling
Nagoya, Japan, 455-8530
Enrolling
Cleveland, Ohio, United States, 44195
Enrolling
Poznan, Poland, 61 731
Enrolling
Tlalnepantla, Mexico, 54055
Enrolling
Toon-shi, Japan, 791-0295
Enrolling
Hradec Králové, Czechia, 500 05
Enrolling
Paris, France, 75019
Enrolling
Pavia, Italy, 27100
Enrolling
Roma, Italy, 00168
Enrolling
Fuzhou, China, 350001
Enrolling
Floridablanca, Colombia, 681004
Enrolling
Coral Springs, Florida, United States, 33067
Enrolling
Nice, France, 06000
Enrolling
Le Kremlin-Bicêtre, France, 94270
Enrolling
Paris, France, 75013
Enrolling
Marseille, France, 13385
Enrolling
Barcelona, Spain, 8035
Enrolling
Madrid, Spain, 28040
Enrolling
Alicante, Spain, 03010
Enrolling
Donostia / San Sebastian, Spain, 20014
Enrolling
Bilbao, Spain, 48013
Enrolling
Seville, Spain, 41009
Enrolling
Bron, France, 69699
Enrolling
Almada, Portugal, 2805-267
Enrolling
Buenos Aires, Argentina, C1428
Enrolling
Buenos Aires, Argentina, C1199ABB
Enrolling
Braga, Portugal, 4710-243
Enrolling
Shanghai, China, 200040
Enrolling
Centennial, Colorado, United States, 80112
Enrolling
Rosario, Argentina, 2900
Enrolling
Rozzano, Italy, 20086
Enrolling
Bunkyō City, Japan, 113 8519
Enrolling
Buenos Aires, Argentina, C1428AQK
Enrolling
Medellín, Colombia, 50021
Enrolling
Milan, Italy, 20133
Enrolling
Baltimore, Maryland, United States, 21287
Enrolling
Berlin, Germany, 13347
Enrolling
Kansas City, Missouri, United States, 64128
Enrolling
Osaka Sayama Shi, Japan, 589 8511
Enrolling
Kumamoto, Japan, 860-8556
Enrolling
Seoul, South Korea, 02447
Enrolling
Hanover, Germany, 30625
Enrolling
Glasgow, United Kingdom, G514TF
Enrolling
Nagoya, Japan, 466-8560
Enrolling
Kodaira-shi, Japan, 187-8551
Enrolling
Asahikawa, Japan, 070-0901
Enrolling
Sendai, Japan, 983-8520
Enrolling
Taipei, Taiwan, 100
Enrolling
Thessaloniki, Greece, 56429
Enrolling
Beijing, China, 100034
Enrolling
Beijing, China, 100191
Enrolling
Lublin, Poland, 20 093
Enrolling
Jinan, China, 250012
Enrolling
Wuhan, China, 430023
Enrolling
Devon, United Kingdom, EX2 5DW
Enrolling
Koshigaya, Japan, 343-8555
Enrolling
Seoul, South Korea, 135-710
Enrolling
Hamamatsu, Japan, 430-8558
Enrolling
Sheffield, United Kingdom, S10 2 JF
Enrolling
Taipei, Taiwan, 111
Enrolling
Chengdu, China, 610072
Enrolling
Patchogue, New York, United States, 11772
Enrolling
Bochum, Germany, 44791
Enrolling
Halle, Germany, 6120
Enrolling
Xi'an, China, 710032
Enrolling
Tenri, Japan, 632-0015
Enrolling
Guangzhou, China, 510080
Enrolling
Nanchang, China, 330006
Enrolling
Changchun, China, 130021
Enrolling
Charlotte, North Carolina, United States, 28204
Enrolling
Ottawa, Canada, K1N 6N5
Enrolling
Changsha, China, 410008
Enrolling
Isehara, Japan, 259-1193
Enrolling
Toyama, Japan, 930-0194
Enrolling
Leipzig, Germany, 4103
Enrolling
Birmingham, United Kingdom, B15 2TH
Enrolling
Kansas City, Kansas, United States, 66160
Enrolling
Xi'an, China, 710075
Enrolling
Changsha, China, 410008
Enrolling
Beijing, China, 100053
Enrolling
Ube, Japan, 755-8505
Enrolling
Monterrey, Mexico, 64710
Completed
Royal Oak, Michigan, United States, 48073
Completed
Boston, Massachusetts, United States, 02111
Completed
Chorzów, Poland, 41 500
Completed
Shimotsuga Gun, Japan, 321 0293
Completed
Ostrava, Czechia, 708 52
Completed
Parkwood, Australia, 4215
Completed
Kaohsiung City, Taiwan, 88301
Completed
Kobe, Japan, 650 0047
Completed
Seoul, South Korea, 05030
Completed
Maitland, Florida, United States, 32751
Completed
Pardubice, Czechia, 53203
Completed
Pátrai, Greece, 26504
Completed
Jinan, China, 250014
Completed
Krakow, Poland, 30 539
Completed
Potsdam, Germany, 14471
Completed
Melbourne, Australia, 3004
Completed
New York, New York, United States, 10032
Completed
Shinjuku-ku, Japan, 162-8666
Completed
Shanghai, China, 200336
Currently on Hold
London, United Kingdom, NW3 2QG
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials